boranes has been researched along with Alloxan Diabetes in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nikolic, I; Saksida, T; Stojanovic, I; Stosic-Grujicic, S; Vujicic, M | 1 |
Fenoy, FJ; Hernandez, I; Li Volti, G; Lopez, B; Perez, C; Rodriguez, F; Salom, MG; Stec, DE | 1 |
2 other study(ies) available for boranes and Alloxan Diabetes
Article | Year |
---|---|
Anti-diabetic actions of carbon monoxide-releasing molecule (CORM)-A1: Immunomodulation and regeneration of islet beta cells.
Topics: Animals; Boranes; Carbonates; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Hypoglycemic Agents; Immunologic Factors; Immunomodulation; Insulin-Secreting Cells; Male; Mice; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2015 |
Chronic tempol treatment attenuates the renal hemodynamic effects induced by a heme oxygenase inhibitor in streptozotocin diabetic rats.
Topics: Animals; Antioxidants; Boranes; Carbon Monoxide; Carbonates; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Hemodynamics; Kidney; Male; Metalloporphyrins; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Circulation; Spin Labels; Time Factors; Tyrosine; Vasoconstriction; Vasodilation | 2011 |